Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Imatinib is still recommended for frontline therapy for CML.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Imatinib is still recommended for frontline therapy for CML.
Imatinib is still recommended for frontline therapy for CML. Blood Adv. 2018 12 26; 2(24):3648-3652.
View in:
PubMed
subject areas
Clinical Trials as Topic
Dose-Response Relationship, Drug
Fusion Proteins, bcr-abl
Humans
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Protein Kinase Inhibitors
Survival Rate
Treatment Outcome
authors with profiles
Richard A. Larson